Gynecologic Disorders Suggests New Screening Options for Cardiovascular Disease, Cancer
Women suffering from three gynecologic disorders may be protected from future heart disease if they carry a specific common genetic variant.
Category: Heart Disease
Heart Disease
Latest
Heart Disease
Latest
Automating the Clinical Lab
The current generation of instruments for in vitro diagnostics is helping to support clinical labs through a strong emphasis on automation.
Heart Disease
Latest
Ava Clinical Trials Indicate Potential Future Use in Pregnancy Detection
In a recent clinical trial conducted in collaboration with the University Hospital of Zurich, the Ava bracelet captured physiological changes known to occur in early pregnancy.
Inside Track: Bacterial Vaginosis: Common, and Silent
Abridged and edited results of a live Q&A session with Donna Mayne, BS, MT(ASCP), (CLS)NCA, microbiology and molecular laboratory manager at Sacred Heart Hospital Pensacola Laboratory, during CLP’s well-attended webcast on “Bacterial Vaginosis: Complications and Diagnostic Options.”
Read MoreNIH Launches Human RSV Study
NIAID study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Read More
NIH Grants Seek Best Ways to Combine Genomic Information and EHRs
Researchers seek to better understand the genomic basis of disease, and provide tailored care to patients.
Read More
Emerging Technologies Promise Revolutionary Diagnostic Tools
Reshaping and broadening the future of lab testing, these diagnostic advances are particularly noteworthy for laboratorians as well as for physicians and patients.
Read More
Recent Trends in Diabetes Diagnosis and Monitoring
With the prevalence of diabetes continuing on an upward trajectory both in the United States and overseas, healthcare professionals are continuing to search for more effective methods of preventing, detecting, and treating the disease.
Read More
Women and Cancer
When it comes to women’s health, molecular diagnostics are playing a bigger role than ever before in uncovering how sex differences are expressed in cancer.
Read MoreAbbott Showcases Innovations in AACC Roundtable
The Abbott Innovation Roundtable at AACC highlighted the company’s latest strides forwards in the molecular diagnostics, point-of-care, and bio-identification sectors.
Read More
Personalized Medicine Progresses
Notable breakthroughs in personalized medicine continue, but reimbursement hurdles and regulation concerns have posed occasional setbacks.
Read More
Cardiovascular Testing
Laboratory testing plays a vital role in keeping tabs on aging women.
Read More
The Role of Genes in Number One Killer of Women
Labs play a vital role in testing women for heart disease.
Read More
Heartland Joint Venture Lab Group to Use Oncimmune Blood Test for Early Detection of Lung Cancer
Mid America Clinical Laboratories is a joint venture clinical laboratory owned by Quest Diagnostics, Community Health Network, St. Vincent Health, and CoLab.
Read More
Promising Results For Tests That Can Help Physicians Better Evaluate Potential Heart Attacks, Study Shows
Studies have found new diagnostic tests in development for heart conditions are expected to help clinicians reduce time to heart attack treatment and potentially improve the way heart attacks are diagnosed in women.
Read MoreBeckman Coulter Study Identifies Heart Attack Risk
Beckman Coulter Inc, Orange County, Calif, announced research results that demonstrated that elevated levels of pregnancy associated plasma protein-A (PAPP-A), as measured by the companys investigative test cPAPP-A, can predict risk of imminent heart attack or death in patients with non-ST segment elevation (NSTE) Acute Coronary Syndrome (ACS).
Read MoreHigh Levels of Triglycerides Linked to Increased Stroke Risk in Older Women
Researchers have found that high levels of triglycerides (blood fats) are the strongest risk factor for the most common type of stroke in older women.
Read MoreNew Test Helps Predict Heart Attack Risk in Women Over Age 50
Researchers concluded that the ratio of apoA1 to remnant lipoproteins is a strong predictor of short- and intermediate-term heart disease risk among women over 50 years of age.
Read More